Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now
Close

Johnson & Johnson (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow J&J's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
163.36 -1.17    -0.71%
20:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
163.77
+0.41
+0.25%
22:19:57 - Real-time Data
  • Volume: 8,959,636
  • Bid/Ask: 163.69 / 163.85
  • Day's Range: 163.32 - 165.74
Type:  Equity
Market:  United States
J&J 163.36 -1.17 -0.71%

JNJ Balance Sheet

 
Assess the latest Johnson & Johnson balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
03/07
2022
03/04
2022
02/01
2021
03/10
Total Current Assets 63847 60424 60979 59889
Cash and Short Term Investments 32568 30388 31608 31001
Cash - 3128 2936 2607
Cash & Equivalents 10983 10463 1901 2120
Short Term Investments 21585 19925 26771 26274
Total Receivables, Net 16139 15594 15283 14911
Accounts Receivables - Trade, Net 16139 15594 15283 14911
Total Inventory 11437 10990 10387 10387
Prepaid Expenses 3703 3452 3701 3590
Other Current Assets, Total - - - -
Total Assets 177724 178355 182018 179228
Property/Plant/Equipment, Total - Net 18354 18701 19862 18478
Property/Plant/Equipment, Total - Gross 47144 47702 47679 47347
Accumulated Depreciation, Total -28790 -29001 -28717 -28869
Goodwill, Net 34166 34935 35246 35569
Intangibles, Net 42408 44420 46392 47776
Long Term Investments 1861 2384 1884 1867
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 7574 7555 17655 15649
Other Assets, Total 26397 25257 - -
Total Current Liabilities 44821 43390 45226 44561
Accounts Payable 9765 9309 11055 8961
Payable/Accrued - - - -
Accrued Expenses 28771 28076 29293 29641
Notes Payable/Short Term Debt 4305 4297 1635 1300
Current Port. of LT Debt/Capital Leases - 497 2131 2498
Other Current liabilities, Total 1980 1708 1112 2161
Total Liabilities 101367 103646 107995 108956
Total Long Term Debt 28292 28851 29985 30130
Long Term Debt 28292 28851 29985 30130
Capital Lease Obligations - - - -
Deferred Income Tax 5015 6424 7487 7147
Minority Interest - - - -
Other Liabilities, Total 18429 20187 25297 27118
Total Equity 76357 74709 74023 70272
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3120 3120 3120 3120
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 126216 124380 123060 121092
Treasury Stock - Common -39136 -39034 -39099 -38525
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - -16 -3 -
Other Equity, Total -13843 -13757 -13055 -15415
Total Liabilities & Shareholders' Equity 177724 178355 182018 179228
Total Common Shares Outstanding 2629.03 2629.38 2628.97 2632.49
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Comments

Write your thoughts about Johnson & Johnson
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lee Baldwin
Lee Baldwin Aug 24, 2022 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interest rates?
ifigeneia ifigeneia
ifigeneia ifigeneia Oct 15, 2021 16:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA approved finally. Few minutes ago!!!!
Lee Baldwin
Lee Baldwin Oct 15, 2021 16:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What?
Lukas Bednall
Lukas Bednall Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
ifigeneia ifigeneia
ifigeneia ifigeneia Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To entry in Spectrum or not? What do you think?
Adam Whipps
Adam Whipps Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Checking it out looks like a good punt
Oc Masai
Oc Masai Apr 24, 2021 11:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job JNJ. move forward bullish
Lee Baldwin
Lee Baldwin Dec 29, 2020 15:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stock split???
Sinisa Galesic
Sinisa Galesic Dec 22, 2020 23:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where we go next?
Paul Strong
Paul Strong Dec 22, 2020 23:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AMC! But ultimately it’s your decision.
Lee Baldwin
Lee Baldwin Oct 29, 2020 16:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy. 0at this price
AdrianQ Khew
AdrianQ Khew Jul 23, 2019 11:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JNJ is going to Make a strong come back tonight!
Bhavesh Parmar
Bhavesh Parmar Dec 17, 2018 1:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Immediate inquiry must be done
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email